Studies of human pancreatic elastase treatment of rabbit and human vein rings to predict human therapeutic doses-Reference-Cited by-同舟云学术

Studies of human pancreatic elastase treatment of rabbit and human vein rings to predict human therapeutic doses

Published:2016-04-02 Issue:3 Volume:4 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Burke Steven K.¹,Bunton David²,Bingham Karen²,Moss Emma²,Bland Kimberly S.¹,Starcher Barry³,Wong Marco D.¹,Franano F. Nicholas¹

Affiliation:

1. Proteon Therapeutics Waltham Massachusetts

2. Biopta, Ltd. Glasgow United Kingdom

3. The University of Texas Health Science Center Tyler Texas

Funder

Proteon Therapeutics, Inc.

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.229

Reference18 articles.

1. In Vivo Vascular Engineering of Vein Grafts: Directed Migration of Smooth Muscle Cells by Perivascular Release of Elastase Limits Neointimal Proliferation

2. Local application of recombinant human type I pancreatic elastase (PRT‐201) to an arteriovenous fistula (AVF) increases AVF blood flow in a rabbit model;Burke SK;J Am Soc Nephrol,2008

3. Time‐ and concentration‐dependent effects of recombinant human elastase (PRT‐201) on the elastin content of human upper extremity veins treated ex vivo;Burke SK;J Am Soc Nephrol,2009

4. Elastase Promotes Aortic Dilation by Inhibiting Ca2+ Influx into Vascular Smooth Muscle

5. Elastolytic and Collagenolytic Studies of Arteries

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PATENCY-2 trial of vonapanitase to promote radiocephalic fistula use for hemodialysis and secondary patency;The Journal of Vascular Access;2021-01-22

2. A randomized trial of vonapanitase (PATENCY-1) to promote radiocephalic fistula patency and use for hemodialysis;Journal of Vascular Surgery;2019-02

3. Arteriovenous fistula patency in the 3 years following vonapanitase and placebo treatment;Journal of Vascular Surgery;2017-04